1-1 of 1
Linda Tegnestam
Close
Sort by
Journal Articles

Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma

Clinical Trials & Observations
Tomer M. Mark, Peter A. Forsberg, Adriana C. Rossi, Roger N. Pearse, Karen A. Pekle, Arthur Perry, Angelique Boyer, Linda Tegnestam, David Jayabalan, Morton Coleman, Ruben Niesvizky
Journal: Blood Advances
Blood Adv (2019) 3 (4): 603–611.
https://doi.org/10.1182/bloodadvances.2018028027
Published: 2019
Includes: Supplemental data